R&D Systems™ Recombinant SARS-CoV-2 Y453F Spike RBD Fc Chimera Protein CF

Catalog No.	Quantity
10792CV100	100 μg

Catalog No. 10792CV100 Supplier R&D Systems™ Supplier No. 10792CV100

Description

Measured by its binding ability in a functional ELISA with Recombinant Human ACE-2 His-tag (Catalog # 933-ZN ).

Specifications

• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Molecular Weight (g/mol): M.W.-observed: 57-64 kDa, under reducing conditions., M.W.-theroretical: 52 kDa
• Quantity: 100 μg
• Source: Human embryonic kidney cell, HEK293-derived sars-cov-2 Spike RBD protein SARS-CoV-2 Spike RBD (Arg319-Phe541)(Tyr453Phe) (N-terminus) Accession # YP_009724390.1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: Spike RBD